Skip to content
America's Blood Centers
  • About
    • Team
    • Board of Directors
    • Committees
    • ABC Strategic Plan
    • ADRP
    • Partners
    • Foundation
  • Advocacy
    • Value Framework
    • 2021 Advocacy Agenda
    • Comments & Letters
    • Resources
  • Events
    • Sponsors
      • Sponsorship Opportunities
    • Awards
  • News
    • January is National Blood Donor Month
    • ABC Publications
    • ABC Coronavirus Resources
  • Membership
    • Join Us
    • Member Resources
    • Membership Directory
    • Get Involved
    • Careers
  • For Donors
    • Convalescent Plasma Donation
    • Blood Donation FAQs
    • Blood Donation 101
    • Blood Donation Types and Collection Procedures
    • Journey of Blood
    • America’s Blood Supply
    • Find a Blood Center
    • Why Donate
  • Contact
FacebookTwitterYoutubeFlickr
  • Member Login
America's Blood Centers
  • About
    • Team
    • Board of Directors
    • Committees
    • ABC Strategic Plan
    • ADRP
    • Partners
    • Foundation
  • Advocacy
    • Value Framework
    • 2021 Advocacy Agenda
    • Comments & Letters
    • Resources
  • Events
    • Sponsors
      • Sponsorship Opportunities
    • Awards
  • News
    • January is National Blood Donor Month
    • ABC Publications
    • ABC Coronavirus Resources
  • Membership
    • Join Us
    • Member Resources
    • Membership Directory
    • Get Involved
    • Careers
  • For Donors
    • Convalescent Plasma Donation
    • Blood Donation FAQs
    • Blood Donation 101
    • Blood Donation Types and Collection Procedures
    • Journey of Blood
    • America’s Blood Supply
    • Find a Blood Center
    • Why Donate
  • Contact
August 21, 2020

ABC Statement on Ongoing Critical Need for COVID-19 Convalescent Plasma Donors

By America's Blood Centers

America’s Blood Centers is the national trade association for independent, community blood centers who collect 60 percent of the nation’s blood supply and more than 80 percent of COVID-19 Convalescent Plasma (CCP). We and our member blood centers continue to support and prioritize both the safe collection and equitable distribution of CCP.

We support the data collection efforts by the U.S. Food and Drug Administration (FDA) to make an informed decision regarding Emergency Use Authorization (EUA) for CCP. It is critical to note that timing of an EUA does not impact any of the current FDA-authorized pathways for distribution of CCP and there remains an ongoing need for additional CCP donors.

More than 130,000 total units of convalescent plasma have been distributed to patients nationwide during the COVID-19 pandemic. Demand for CCP remains high and can only be met through voluntary donations by individuals who have fully recovered from COVID-19. Currently, convalescent plasma is being distributed under investigational status, through either clinical trials, the expanded access protocol (EAP), or single patient emergency INDs (eINDs).

The safety of CCP for COVID-19 patients has been demonstrated. While convalescent plasma is a long-standing therapy used in previous pandemics, and specifically for other coronaviruses (SARS and MERS), the efficacy of CCP for COVID-19 is still being evaluated. America’s Blood Centers and our member blood centers remain committed to these studies and to their success.

The safety of CCP and the need for additional CCP donors has been recognized by public health leaders from multiple federal agencies. We join their message in strongly encouraging individuals who have had COVID-19 and have since fully recovered to donate convalescent plasma at your local blood center. The center nearest you can be found at www.AmericasBlood.org.

Download statement.

Posted in News, Statements
Share this

Recent Posts

  • Joint Statement on the Widespread Snow and Ice Disrupting Nation’s Blood Supply
  • Joint Comments Submitted – Most Favored Nation (MFN) Model (CMS-5528-IFC)
  • Blood Community Encourages Individuals to Donate Blood, Convalescent Plasma During National Blood Donor Month and Beyond
  • ADRP has been awarded a grant from Terumo Blood and Cell Technologies
  • Joint Letter to FDA Regarding COVID-19 Convalescent Plasma (CCP) Emergency Use Authorization (EUA) Implementation

Categories

  • Advocacy News
  • Letters
  • Letters and Comments
  • News
  • Press Releases
  • Statements

Subscribe for Updates

Sign up to receive updates from America’s Blood Centers.

* indicates required

America's Blood Centers
1717 K Street NW, Suite 900
Washington, DC 20006

Tel: 202-393-5725

Fax: 202-899-2621

  • About
    • Team
    • Board of Directors
    • Committees
    • ABC Strategic Plan
    • ADRP
    • Partners
    • Foundation
  • Advocacy
    • Value Framework
    • 2021 Advocacy Agenda
    • Comments & Letters
    • Resources
  • Events
    • Sponsors
      • Sponsorship Opportunities
    • Awards
  • News
    • January is National Blood Donor Month
    • ABC Publications
    • ABC Coronavirus Resources
  • Membership
    • Join Us
    • Member Resources
    • Membership Directory
    • Get Involved
    • Careers
  • For Donors
    • Convalescent Plasma Donation
    • Blood Donation FAQs
    • Blood Donation 101
    • Blood Donation Types and Collection Procedures
    • Journey of Blood
    • America’s Blood Supply
    • Find a Blood Center
    • Why Donate
  • Contact
  • Sitemap
  • Privacy Policy
  • Terms of Use
Become a Member
Member Login

Copyright © 2021 © America’s Blood Centers. All Rights Reserved.

Website by Yoko Co

Scroll To Top